The Mentor Capital Cancer Immunotherapy Index ^©

* Cancer Immunotherapy Index developed with Mike Havrilla, PhD., Editor of BioMedReports.com, as a sub-set to his Cancer Diagnostic & Therapeutic Micro-Cap Index.
** Reflects Market Cap of Mentor Capital with 100% of Quantum Immunologics.
*** Market Data from National Cancer Institute based on Relative Mortality in company treatment areas & 50% penetration by immunotherapy sector into cancer treatments.

 Click to see larger